Access Biotechnology Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 54

  • Portfolio
  • 14

  • Exits
  • 24

Exits

Access Biotechnology General Information

Company Description

Founded in 2019, Access Biotechnology is the corporate venture arm of Access Industries, based in New York. The firm seeks to invest in pre-clinical and clinical companies developing therapeutic platforms and products. The firm seeks to invest in the biotech sector.

Business Details

Year Founded
2019
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Corporate Office
  • 40 West 57th Street
  • 28th Floor
  • New York, NY 10019
  • United States
+1 (212)

Access Biotechnology Investments (54)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Velaris Therapeutics 13-Oct-2026 PIPE Drug Discovery Generating Revenue
Matchpoint Therapeutics 07-Oct-2026 Biotechnology Generating Revenue
Talawar Tx 29-Jun-2026 Drug Discovery Generating Revenue
OnKure Therapeutics 27-Mar-2026 Biotechnology Clinical Trials - Phase 1
Vima Therapeutics 11-Mar-2026 Drug Discovery Clinical Trials - Phase 1
Recludix Pharma 12-Jan-2026 Drug Discovery Clinical Trials - General
Hemab Therapeutics Holdings 27-Oct-2025 Holding Companies Generating Revenue
Draig Therapeutics 18-Jun-2025 Drug Discovery Clinical Trials - Phase 2
Surrozen 26-Mar-2025 PIPE Drug Discovery Generating Revenue/Not Profitable
Latigo Bio 17-Mar-2025 Later Stage VC Biotechnology Generating Revenue/Not Profitable
You’re viewing 10 of 54 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Access Biotechnology Exits (24)

Company Name Exit Date Exit Type Exit Size
Latigo Bio 06-Aug-2026 IPO
VYNE Therapeutics 27-Jun-2026
Perfuse Therapeutics 17-Jun-2026
Hemab Therapeutics Holdings 01-May-2026
Oruka Therapeutics 28-Apr-2026
Halda Therapeutics 26-Dec-2025
Verona Pharma 07-Oct-2025
Spyre Therapeutics 19-Nov-2024
Upstream Bio 11-Oct-2024 IPO
Mariana Oncology 02-May-2024 Merger/Acquisition
You’re viewing 10 of 24 exits. Get the full list »

Access Biotechnology Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Access Biotechnology Co-Investors (88)

Name With Exits Lead Partner Series Industry
Atlas Venture 5 Series chart Industry bar
Deep Track Capital Series chart Industry bar
RA Capital Management Series chart Industry bar
Canaan Partners Series chart Industry bar
OrbiMed Series chart Industry bar
You’re viewing 5 of 88 co-investors. Get the full list »

Access Biotechnology FAQs

  • What is Access Biotechnology?

    Founded in 2019, Access Biotechnology is the corporate venture arm of Access Industries, based in New York.

  • When was Access Biotechnology founded?

    Access Biotechnology was founded in 2019.

  • Where is Access Biotechnology headquartered?

    Access Biotechnology is headquartered in New York, NY.

  • How many investments has Access Biotechnology made?

    Access Biotechnology has made 54 investments.

  • What has Access Biotechnology invested in?

    Access Biotechnology has made numerous investments in companies like Velaris Therapeutics, Matchpoint Therapeutics, and Talawar Tx within the Drug Discovery and Biotechnology industries.

  • What has Access Biotechnology invested in recently?

    Access Biotechnology's latest investment was on 13-Oct-2026 in Velaris Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process